Skip to main content

Table 5 Associations between serum iron and liver transaminases in the sensitivity analyses

From: Association between serum iron and liver transaminases based on a large adult women population

 

Model 1, β (95% CI)

Model 2, β (95% CI)

Model 3, β (95% CI)

A

0.009 (− 0.009, 0.026)

0.006 (− 0.012, 0.024)

0.007 (− 0.011, 0.025)

B

0.010 (− 0.003, 0.023)

0.004 (− 0.010, 0.018)

0.004 (− 0.010, 0.018)

C

0.001 (− 0.008, 0.009)

0.016 (0.008, 0.025)***

0.016 (0.008, 0.025)***

D

0.007 (− 0.001, 0.015)

0.009 (0.001, 0.017)*

0.009 (0.001, 0.017)*

E

0.010 (0.003, 0.016)***

0.024 (0.017, 0.030)***

/

F

0.015 (0.009, 0.020)***

0.015 (0.010, 0.021)***

/

  1. Bold indicates a statistical difference. *P < 0.05, **P < 0.01, ***P < 0.001. A: The association between serum iron and ALT in pregnant women. B: The association between serum iron and AST in pregnant women. C: The association between serum iron and ALT in non-pregnant women. D: The association between serum iron and AST in non-pregnant women. E: The association between serum iron and ALT after excluding participants with HBP, diabetes, and CKD. F: The association between serum iron and AST after excluding participants with HBP, diabetes, and CKD. In the A, B, C, and D, model 1 was not adjusted; model 2 was adjusted for age, race, education, family income-poverty ratio, BMI, alcohol drinking, smoking exposure, cholesterol, glucose, triglycerides, and work activity; and model 3 was adjusted for model 2 plus histories of HBP, diabetes, and CKD. In the E and F, model 1 was not adjusted, and model 2 was adjusted for age, race, education, family income-poverty ratio, pregnancy status, BMI, alcohol drinking, smoking exposure, cholesterol, glucose, triglycerides, and work activity
  2. ALT alanine aminotransferase, AST aspartate aminotransferase, BMI body mass index, HBP high blood pressure, CKD chronic kidney disease